By Duncan Bridgeman
|
Friday 23rd May 2003 |
Text too small? |
The 17% lift in profit was in line with expectations, pushing Healthcare shares up another 5c to $10.75 at press time yesterday.
Chief executive Michael Daniell said the company was planning a number of
significant new product introductions, including sleeping masks, humidifier systems, breathing circuits and patient warmers.
The result included realised and unrealised foreign exchange gains of $23 million after tax.
Operating revenue for the company's core product range grew 17% in US dollar terms over the previous year.
Mr Daniell said the company expected a continuation of strong US dollar revenue growth.
Fisher & Paykel makes heated humidification products for use in respiratory care and treatment of obstructive sleep apnea (OSA), a condition that stops breathing during sleep.
No comments yet
Metro Performance Glass FY26 Market Update
Devon Funds Morning Note - 13 March 2026
Devon Funds Morning Note - 12 March 2026
TCM - Financial Model
BRM - Scheme of Arrangement Update - NZ Commerce Commission
Devon Funds Morning Note - 11 March 2026
BGP - Full Year Results to 25 January 2026
BRM - Scheme of Arrangement Update - NZ Commerce Commission
The oil shock
Air New Zealand suspends FY2026 guidance